During the past decade, High Technology Hospital MedCenter conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 1 clinical trials were completed, i.e. on average, 5.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 1 clinical trials were completed. i.e. 6.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "High Technology Hospital MedCenter" #1 sponsor was "Biocad" with 2 trials, followed by "Incyte Corporation" with 2 trials sponsored, "Aravive, Inc." with 1 trials sponsored, "BeiGene" with 1 trials sponsored and "EirGenix, Inc." with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "High Technology Hospital MedCenter" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 2 trials as a collaborator, "GOG Foundation" with 2 trials as a collaborator, "Everest Medicines" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "High Technology Hospital MedCenter" are "Non-small Cell Lung Cancer" (2 trials), "Aged" (1 trials), "Breast Cancer" (1 trials), "Cervical Cancer" (1 trials) and "Dedifferentiated Liposarcoma" (1 trials). Many other conditions were trialed in "High Technology Hospital MedCenter" in a lesser frequency.

Most popular intervention types in "High Technology Hospital MedCenter" are "Drug" (17 trials), "Biological" (4 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Paclitaxel" (5 trials), "BCD-100" (2 trials), "Bevacizumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "High Technology Hospital MedCenter" are 12 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "High Technology Hospital MedCenter". undefined are not yet recruiting, 10 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in High Technology Hospital MedCenter, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in High Technology Hospital MedCenter, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".